Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History).

To determine (1) the medium-term effect of rosiglitazone and glipizide on intra-stent neointima hyperplasia, (2) restenosis pattern as assessed by intra-vascular ultrasound (IVUS) and quantitative coronary angiography (QCA) in patients with T2DM and coronary artery disease. A total of 462 patients with T2DM were randomized to rosiglitazone or glipizide for up to 18 months in the APPROACH trial, and had evaluable baseline and follow-up IVUS examinations. There was no significant difference in the size of plaque behind stent between the rosiglitazone and glipizide groups at 18 months among those treated with a bare metal stent (-5.

High resolution electronic spectroscopy of 9-fluorenemethanol in the gas phase: new insights into the properties of Π-hydrogen bonds.

Rotationally resolved S(1)←S(0) fluorescence excitation spectra of 9-fluorenemethanol (9FM) and deuterated 9-fluorenemethanol (9FMD) have been observed and assigned. Two conformers were detected; sym-9FM and unsym-9FM. The sym conformer has the -OH group symmetrically placed above the fluorene short axis, with its hydrogen atom pointing towards the top of an aromatic ring, whereas the unsym conformer has the -OH group tilted away from this axis, with its hydrogen atom pointing towards the side of an aromatic ring.

Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial.

Background: Rosiglitazone has several properties that may affect progression of atherosclerosis. The Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History (APPROACH) study was undertaken to determine the effect of the thiazolidinedione rosiglitazone on coronary atherosclerosis as assessed by intravascular ultrasound compared with the sulfonylurea glipizide.

Methods And Results: This was a randomized, double-blind, controlled 18-month study in 672 patients aged 30 to 80 years with established type 2 diabetes mellitus treated by lifestyle, 1 oral agent, or submaximal doses of 2 oral agents who had at least 1 atherosclerotic plaque with 10% to 50% luminal narrowing in a coronary artery that had not undergone intervention during a clinically indicated coronary angiography or percutaneous coronary intervention.

On the electric dipole moments of asymmetric tops: measurement by high-resolution electronic spectroscopy in the gas phase.

Reported here are Stark-effect measurements of the permanent electric dipole moments of two structural isomers of aminobenzonitrile, 2ABN and 3ABN, using high-resolution laser molecular beam techniques. When combined with previous results on 4ABN, the data show that each structural isomer has a unique dipole moment, in both its ground (S(0)) and electronically excited (S(1)) states, thereby providing a means of distinguishing them. Possible applications of the method to other, biologically relevant molecules are discussed.